Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 5,414,146	$ 20,729,983
Accounts receivable	312,611	242,617
Prepaid expenses	689,995	521,370
Other current assets	384,189	360,125
Total Current Assets	6,800,941	21,854,095
Property and equipment, net	4,908,148	5,523,013
Operating lease right-of-use assets	635,857	549,504
Intangible assets, net	335,309	23,886
Total Assets	12,680,255	27,950,498
Current Liabilities
Accounts payable	2,485,077	3,211,287
Accrued liabilities	3,480,207	3,928,761
Deferred revenue	22,893,400	23,000,000
Management and directors' fees payable	24,851	59,625
Current portion of long-term debt	965,021	1,207,007
Current portion of finance lease liabilities	49,990	48,570
Current portion of operating lease liabilities	219,060	199,323
Current portion of grant repayable	65,646	55,855
Warrant liability	96,225	126,649
Total Current Liabilities	30,279,477	31,837,077
Long-term debt, net of current portion	3,837,950	3,624,860
Finance lease liabilities, net of current portion	366,175	400,022
Operating lease liabilities, net of current portion	448,045	378,054
Grant repayable, net of current portion	388,898	422,707
Total Long-Term Liabilities	5,041,068	4,825,643
Total Liabilities	35,320,545	36,662,720
Stockholders' Deficit
Common Stock Authorized: 175,000,000 shares of common stock, at $0.001 par value per shareIssued and outstanding: 92,392,570 shares and 81,898,321 shares, respectively	92,393	81,898
Additional paid-in capital	202,014,277	194,448,414
Accumulated other comprehensive income	140,272	243,940
Accumulated deficit	(223,750,970)	(202,576,507)
Total VolitionRx limited Stockholders' Deficit	(21,504,028)	(7,802,255)
Non-controlling interest	(1,136,262)	(909,967)
Total Stockholders' Deficit	(22,640,290)	(8,712,222)
Total Liabilities and Stockholders' Deficit	$ 12,680,255	$ 27,950,498